thrombotic events

Related by string. Thrombotic events * Thrombotic : thrombotic thrombocytopenic purpura TTP . thrombotic disorders malignant neoplasm . anti thrombotic Lovenox . anti thrombotic . thrombotic disorders / eventing . EVENTS . EVENT . Events . Eventing : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center . Corporate Event Announcement * venous thrombotic events *

Related by context. All words. (Click for frequent words.) 79 thromboembolic events 77 thromboembolism 77 Erythropoietic therapies may 75 hyperkalemia 74 thrombotic complications 73 venous thromboembolism 72 hepatotoxicity 72 hemorrhagic complications 72 COPD exacerbations 72 intracerebral hemorrhage 72 reinfarction 72 β blockers 72 arterial thromboembolic events 72 ischemic complications 71 recurrent VTE 71 hypercalcemia 71 upper gastrointestinal bleeding 71 myocardial infarctions 71 thromboembolic 71 thromboembolic complications 71 fatal myocardial infarction 71 antiplatelet drugs 71 myocardial infarction MI 71 venous thromboembolic events 70 myopathy rhabdomyolysis 70 periprocedural 70 nephrotoxicity 70 myocardial infarction stroke 70 thromboembolic disease 70 cerebrovascular events 70 ATACAND 70 prolonged QT interval 70 venous thrombosis 70 recurrent ischemia 69 microvascular complications 69 angina pectoris 69 spontaneous preterm delivery 69 microvascular disease 69 antiplatelet medications 69 postoperative AF 69 atherothrombotic events 69 macrovascular events 69 unstable angina pectoris 69 beta blocker therapy 69 Torsades de Pointes 69 QT prolongation 69 left ventricular dysfunction 69 rebleeding 69 KIF6 carriers 69 severe hypersensitivity reactions 69 renal insufficiency 68 myocardial ischemia 68 recurrent DVT 68 torsades de pointes 68 ticlopidine 68 MULTAQ 68 postoperative atrial fibrillation 68 intravenous bisphosphonates 68 myocardial infarction 68 endometrial hyperplasia 68 symptomatic intracranial 68 rFVIIa 68 HMG CoA reductase inhibitors 68 tumor lysis syndrome 68 silent ischemia 68 cardiovascular mortality 68 carotid stenosis 68 colorectal adenoma 68 non valvular atrial 68 Stent thrombosis 68 cardiac toxicity 68 hemorrhagic strokes 68 ximelagatran 68 renal toxicity 68 pericardial effusion 68 torsade de pointes 68 definite stent thrombosis 68 infarctions 68 induce orthostatic hypotension 68 nicardipine 68 salmeterol HFA MDI 67 perioperative complications 67 macrovascular 67 extrapyramidal symptoms 67 renal dysfunction 67 paroxysmal AF 67 haemorrhagic stroke 67 renal impairment 67 cardiovascular hospitalizations 67 recurrent venous thromboembolism 67 valsartan 67 mycophenolate mofetil 67 amiodarone 67 lumiracoxib 67 intracranial hemorrhage ICH 67 lactic acidosis 67 ischemic cardiomyopathy 67 thrombolytic agents 67 nonfatal MI 67 VIIBRYD 67 cardiovascular ischemic 67 symptomatic VTE 67 cardiovascular hospitalization 67 venous thromboembolic disease 67 candesartan 67 severe exacerbations 67 vasospasm 67 ARCOXIA 67 anticoagulants blood thinners 67 sotalol 67 NATRECOR ® 67 QTc prolongation 67 EXJADE 67 TEAEs 67 cerebral ischemia 67 ipsilateral stroke 67 rhythm disturbances 67 perioperative mortality 67 contrast induced nephropathy 67 recurrent atrial fibrillation 66 VT VF 66 elevated triglyceride levels 66 refractory ischemia 66 antithrombotic therapy 66 nonvertebral fractures 66 variceal bleeding 66 TMP SMX 66 systemic embolism 66 noncardiovascular 66 venous blood clots 66 coadministration 66 endophthalmitis 66 VTE 66 cardiovascular morbidity 66 aspirin clopidogrel 66 angioedema 66 heparin induced thrombocytopenia 66 acute coronary syndromes ACS 66 AVANDIA 66 antiplatelet therapy 66 stable angina 66 fluvastatin 66 hypomagnesemia 66 deep venous thromboses 66 tolvaptan 66 NOLVADEX 66 CMV infection 66 dronedarone 66 cardiac dysfunction 66 idraparinux 66 thrombosis 66 syncopal 66 postoperative infections 66 hypercalcaemia 66 metabolic acidosis 66 repeat revascularization 66 recurrent myocardial infarction 66 hyperglycaemia 66 cardioembolic stroke 66 Hypotension 66 antiplatelet agent 66 potassium sparing diuretics 66 PRADAXA #mg 66 thienopyridines 66 tachyarrhythmias 66 venous thromboembolisms 66 lichen planus 65 nonvertebral fracture 65 MACCE 65 glitazones 65 ventricular arrhythmia 65 cerebral infarction 65 Atacand 65 eplerenone 65 acute myocardial infarction AMI 65 angiotensin receptor blockers 65 thromboses 65 octreotide LAR 65 stent thromboses 65 antiarrhythmic drug 65 decompensated heart failure 65 nonischemic 65 serum phosphate 65 Pulmonary embolism 65 recurrent UTI 65 glycated hemoglobin levels 65 anticoagulant warfarin 65 IIIa inhibitor 65 cardiotoxicity 65 lipid lowering drugs 65 PLAVIX 65 Thrombocytopenia 65 thrombocytopenic 65 ARIXTRA 65 postoperative mortality 65 ischemic stroke 65 arterial thrombosis 65 cerebral vasospasm 65 serum calcium levels 65 postoperative morbidity 65 benazepril 65 CMV disease 65 LV dysfunction 65 venlafaxine Effexor 65 sustained ventricular tachycardia 65 coronary revascularization procedures 65 receiving VELCADE 65 Rasilez Tekturna 65 revascularizations 65 proliferative diabetic retinopathy 65 systemic corticosteroids 65 unstable angina 65 binary restenosis 65 adrenal insufficiency 65 atherothrombotic 65 angina myocardial infarction 65 TNF antagonist 65 HF hospitalization 65 Venous thromboembolism 65 atherothrombotic disease 65 ABCB1 65 atrial arrhythmias 65 hematologic toxicity 65 nonmelanoma skin cancers 65 Febrile neutropenia 65 neurologic complications 65 aldosterone antagonist 65 hepatic failure 65 gastrointestinal perforation 65 gastrointestinal toxicity 65 hypoglycemic events 65 nonfatal stroke 65 systolic dysfunction 65 DVT PE 65 morphometric vertebral fractures 65 olmesartan 65 subclinical hypothyroidism 65 CVD mortality 65 liver transaminases 65 MIs 65 VTEs 65 angiotensin converting enzyme inhibitors 65 GI bleeds 65 ventricular tachycardia VT 65 advanced adenoma 65 hypoglycemic episodes 65 cranial irradiation 65 bezafibrate 65 nadolol 65 ischemic strokes 65 GnRH agonists 65 antiplatelet agents 64 Celebrex celecoxib 64 hypercholesterolaemia 64 prednisone prednisolone 64 vasomotor symptoms 64 intracranial bleeding 64 ventricular arrhythmias 64 ICD shocks 64 atypical fractures 64 cobiprostone 64 leiomyomas 64 QT interval prolongation 64 cerebrovascular accidents 64 tamsulosin 64 colorectal adenomas 64 fluid overload 64 postoperative pulmonary 64 thienopyridine 64 serum creatinine levels 64 acute coronary syndromes 64 irbesartan 64 antiarrhythmic drugs 64 fibrinolytic 64 aldosterone antagonists 64 fondaparinux 64 dyslipidaemia 64 carotid artery blockage 64 primidone 64 atherosclerotic vascular disease 64 severe neutropenia 64 acute coronary 64 thrombotic 64 lipid lowering agents 64 posaconazole 64 ADHF 64 Lactic acidosis 64 systolic hypertension 64 tibolone 64 verapamil 64 bone marrow suppression 64 clopidogrel Plavix 64 recurrent stroke 64 Unstable angina 64 hepatic toxicity 64 invasive fungal infections 64 orthostatic hypotension 64 bacteriuria 64 atrophic gastritis 64 cytopenias 64 INTEGRILIN R 64 tardive dyskinesia TD 64 angiotensin converting enzyme inhibitor 64 hydroxychloroquine 64 endometrial carcinoma 64 valdecoxib 64 clopidogrel 64 reblockage 64 strong CYP#A# inducers 64 intracerebral haemorrhage 64 Postoperative complications 64 persistent pulmonary hypertension 64 ocular adverse 64 stent thrombosis 64 polyp recurrence 64 reoperations 64 Toxicities 64 revascularization procedures 64 thromboprophylaxis 64 KETEK 64 Renal impairment 64 atherosclerotic disease 64 vertebral fracture 64 ventricular fibrillation VF 64 ischemic cardiovascular 64 acute myocardial infarction MI 64 paroxetine Paxil 64 unknown etiology 64 transaminase elevations 64 NSAID induced 64 de ath 64 PAOD 64 GP IIb IIIa inhibitors 64 thyrotoxicosis 64 deferiprone 64 coronary blockages 64 recurrent ischemic 64 deep vein thromboses 64 angiotensin receptor blockers ARBs 64 postoperative delirium 64 ß blockers 64 metformin accumulation 64 TORISEL 64 cardiogenic shock 64 TAXUS Express Stent 64 patients undergoing CABG 64 thrombolytics 64 atherosclerotic progression 64 hyperprolactinemia 64 severe hypoglycemia 64 Peripheral edema 64 cardiac tamponade 64 gouty arthritis 64 gout flares 64 nonfatal myocardial infarction 64 periprocedural MI 64 QTc interval 64 discontinuations due 64 restenosis 64 neointimal hyperplasia 64 antiplatelet medication 64 pulmonary exacerbations 64 hypoglycaemic episodes 64 necrotizing pancreatitis 64 Angioedema 64 hyperbilirubinemia 64 infective endocarditis 64 atherothrombosis 64 dexrazoxane 64 cerebrovascular accident 64 anticoagulants 63 ovarian hyperstimulation syndrome OHSS 63 pancytopenia 63 FASLODEX 63 albuminuria 63 valvular disease 63 venous thromboembolic 63 virologic failure 63 perioperatively 63 Dasatinib 63 urinary retention 63 cryptogenic stroke 63 infarction STEMI 63 nonhematologic adverse reactions 63 familial hypercholesterolemia 63 inhospital 63 adrenal suppression 63 Tardive dyskinesia 63 intraoperative complications 63 invasive aspergillosis 63 oral antidiabetic medication 63 invasive candidiasis 63 indomethacin 63 Primary Hypercholesterolemia 63 proximal DVT 63 dosing frequency 63 variceal hemorrhage 63 flutamide 63 anticlotting drugs 63 antihypertensive drugs 63 neutropenia dehydration dyspnea 63 VaD 63 microbleeds 63 angiographic restenosis 63 hyperphenylalaninemia HPA due 63 thrombogenic 63 noncardiac 63 acute coronary syndrome 63 vertebral fractures 63 cilostazol 63 APTIVUS r 63 fibrinolysis 63 pericardial effusions 63 poor metabolizers 63 malarial anemia 63 ventricular tachyarrhythmia 63 febrile neutropenia 63 retransplantation 63 CYP #A# 63 Statin therapy 63 dopaminergic therapy 63 omeprazole Prilosec 63 coagulopathy 63 BYSTOLIC 63 Exacerbations 63 angina chest 63 syncope fainting 63 Hemorrhagic strokes 63 dermatologic reactions 63 hypoperfusion 63 interstitial pneumonia 63 neuropsychiatric symptoms 63 arterial calcification 63 Lp PLA2 63 telmisartan 63 unstable angina UA 63 receiving prophylactic anticoagulation 63 hepatorenal syndrome 63 ranolazine 63 dysrhythmias 63 macrovascular disease 63 Myfortic 63 decompensation 63 noncardiovascular mortality 63 phenytoin 63 NATRECOR R 63 nonfatal myocardial infarction MI 63 anticoagulant therapy 63 thrombus formation 63 loop diuretics 63 metoprolol tartrate 63 renal scarring 63 warfarin Coumadin 63 TAXUS Stent 63 serum cholesterol 63 nonselective NSAIDs 63 carotid plaque 63 nonmelanoma skin cancer 63 platelet reactivity 63 Combination therapy 63 selective NSAIDs 63 gemfibrozil 63 prescribed statins 63 ACTOplus met XR 63 elevated LDL cholesterol 63 infarction NSTEMI 63 beta blockers ACE inhibitors 63 CHD mortality 63 coronary artery disease 63 events TEAEs 63 Hydroxyurea 63 ST elevation myocardial 63 dalteparin 63 revascularisation 63 subclinical hyperthyroidism 63 antibiotic prophylaxis 63 antiphospholipid syndrome 63 bronchopulmonary dysplasia 63 thiazide diuretic 63 platelet inhibition 63 mixed hyperlipidemia 63 acute decompensation 63 cardiovascular disease CVD 63 vesicoureteral reflux 63 coronary revascularization 63 acarbose 63 cardiac conduction 63 tirofiban 63 rosuvastatin Crestor 63 postoperative complications 63 NNT = 63 PRADAXA 63 lipid lowering medications 63 uncontrolled bleeding 63 hypoxemia 63 cholecystitis 63 diabetic kidney 63 post thrombotic syndrome 63 Events MACE 63 serum uric acid 63 cerebral microbleeds 63 corticosteroid therapy 63 chlorthalidone 63 intensive statin therapy 63 VAPRISOL 63 variceal 63 advanced adenomas 63 restenosis reblockage 63 fatal anaphylactic 63 statins cholesterol lowering 63 thrombophilia 63 proteinuria 63 pulmonary emboli 63 oral antidiabetic drugs 63 nephrotoxic drugs 63 Uncontrolled hypertension 63 platelet activation 62 asthma exacerbations 62 nocturnal hypoglycaemia 62 seropositive patients 62 lipid lowering therapies 62 Pioglitazone 62 thiazide 62 reintervention 62 patients undergoing percutaneous 62 alteplase 62 acute myocardial infarctions 62 Unstable Angina 62 paclitaxel eluting stents 62 cardiovascular disease hypertension 62 oxcarbazepine 62 fetal malformations 62 events MACE 62 pyrexia mucositis sepsis febrile 62 venous thromboembolism VTE 62 recurrent miscarriage 62 hypophosphatemia 62 CIMZIA ™ 62 rosuvastatin #mg 62 Hypocalcemia 62 sodium valproate 62 ULORIC 62 stent implantation 62 neutropenic patients 62 mycophenolic acid 62 serum potassium 62 segment elevation myocardial 62 antihypertensive medications 62 Restenosis 62 PASI scores 62 ezetimibe simvastatin 62 atrial fibrillation AF 62 kidney dysfunction 62 serum aminotransferase levels 62 hypoglycemia 62 thrombophlebitis 62 vascular inflammation 62 paricalcitol 62 lipid parameters 62 antiarrhythmic 62 hematologic adverse 62 reperfusion injury 62 alpha interferons 62 pulmonary toxicity 62 ventricular dysfunction 62 atopic disease 62 secondary hyperparathyroidism 62 arrhythmias 62 colon perforation 62 angiotensin II receptor blockers 62 esomeprazole Nexium 62 aminotransferases 62 voriconazole 62 CYPHER ® 62 leukotriene receptor antagonists 62 prophylactic therapy 62 ocular toxicity 62 clomipramine 62 recurrent wheezing 62 Warfarin Coumadin 62 statin medications 62 antithrombotic 62 cirrhotic patients 62 LOVENOX R 62 Rivaroxaban 62 β blocker 62 enoxaparin 62 troponin T 62 Reversible Posterior Leukoencephalopathy Syndrome 62 lipid abnormalities 62 systemic hypotension 62 candidemia 62 revascularisation procedures 62 antithrombotics 62 STRIDE PD 62 azacitidine 62 Hypoglycemia 62 DAPT 62 severe hypoglycemic 62 myocardial fibrosis 62 H2 receptor antagonists 62 sirolimus eluting stents 62 carvedilol 62 hypocalcemia 62 thrombi 62 peripheral arterial occlusive disease 62 haloperidol Haldol 62 malignant neoplasms 62 androgen deprivation 62 PREZISTA r 62 spine fractures 62 ticagrelor 62 Hematologic 62 ribavirin therapy 62 stroke transient ischemic 62 pharmacokinetic interactions 62 locoregional recurrence 62 hydroxymethyl coenzyme 62 anemia neutropenia 62 HIV HCV coinfected 62 Candesartan 62 gastric varices 62 mitochondrial toxicity 62 losartan Cozaar 62 erythropoietic 62 systemic toxicity 62 gastrointestinal bleeds 62 cerivastatin 62 warfarin 62 labetalol 62 anastomotic leak 62 myeloperoxidase 62 resuscitated cardiac arrest 62 cardiac insufficiency 62 pulmonary hypertension PH 62 autoimmune reactions 62 atrial tachyarrhythmias 62 prothrombotic 62 Eltrombopag 62 Hypersensitivity reactions 62 thromboembolisms 62 myocardial infarctions MIs 62 distal embolization 62 elevated ALT 62 hallucinations dyskinesia 62 pheochromocytoma 62 Aprotinin 62 liver toxicity 62 NOMID 62 renoprotective 62 hyperparathyroidism 62 Avandia Actos 62 undergoing coronary artery 62 ruptured aneurysms 62 TNF blocker therapy 62 Hepatotoxicity 62 gastrointestinal GI bleeding 62 NIASPAN 62 acute gout flares 62 catheter angiography 62 STEMIs 62 non metastatic osteosarcoma 62 thrombo embolic 62 zotarolimus 62 ARCALYST ® 62 intima media thickness 62 ACTOplus met 62 endoleaks 62 trimethoprim sulfamethoxazole 62 DES implantation 62 cinacalcet 62 coronary intervention 62 Vitamin D insufficiency 62 efalizumab 62 VTE prophylaxis 62 glitazone class 62 vWD 62 pioglitazone 62 leucopenia 62 edoxaban 62 postoperative complication 62 FluCAM arm 62 Contrast Induced Nephropathy CIN 62 bosentan 62 DVTs 62 H2 blockers 62 systemic corticosteroid 62 FOLFOX4 62 renal flares 62 homozygous familial hypercholesterolemia 62 hypersensitivity reaction 62 graft occlusion 62 left ventricular systolic 62 anaphylactoid reactions 62 thrombolytic therapy 62 REOPRO 62 T2DM 62 allograft rejection 62 amifostine 62 AST ALT 62 HoFH 62 invasive fungal infection 62 lipid lowering therapy 62 anterior uveitis 62 sulphonylureas 62 hypervascular tumors 62 intravascular hemolysis 62 bradycardia 62 uncoated stents 62 serum BDNF 62 paroxysmal atrial fibrillation 62 asthma exacerbation 62 GISTs 62 Doxil ® 62 Diovan HCT 62 spontaneous preterm birth 61 candesartan cilexetil 61 rosuvastatin 61 HeFH 61 symptomatic hypotension 61 acute phosphate nephropathy 61 colorectal liver metastases 61 antihypertensive therapy 61 hypersensitivity reactions 61 sirolimus stent 61 acute GVHD 61 oral anticoagulant 61 amenorrhoea 61 Rofecoxib 61 breast endometrial 61 pioglitazone Actos 61 atypical femur fractures 61 TZDs 61 elevated IOP 61 hormone therapy HT 61 infarct size 61 Bivalirudin 61 lamotrigine 61 Ischemic 61 alanine aminotransferase 61 conventional antipsychotics 61 parecoxib 61 prostate carcinogenesis 61 XIENCE V PROMUS Stent 61 delayed CINV 61 digoxin toxicity 61 eosinophilic pneumonia 61 occlusive disease 61 VEGF inhibitors 61 IFN beta 61 Thrombotic events 61 abnormal uterine bleeding 61 Pseudomonas aeruginosa infections 61 preserved ejection fraction 61 ICD implantation 61 nonfasting triglycerides 61 thrombocytosis 61 TAXUS Liberte Long 61 simvastatin ezetimibe 61 severe renal impairment 61 dermatologic toxicities 61 non selective NSAIDs 61 cerebrovascular disease 61 autoantibody levels 61 inhaled budesonide 61 oral anticoagulants 61 adalimumab 61 COREG 61 coronary stenosis 61 paroxetine sertraline 61 serum calcium 61 ACTOS 61 ACE inhibitor ramipril 61 hypotensive 61 PLX STROKE targeting 61 preterm delivery 61 hemodynamic instability 61 adalimumab Humira 61 nifedipine 61 dual antiplatelet therapy 61 G6PD deficiency 61 elevated uric acid 61 salmeterol fluticasone 61 Severe hypoglycemia 61 dysglycemia 61 acitretin 61 captopril 61 QTc intervals 61 AAT deficiency 61 stenoses 61 severe hepatomegaly 61 gallstone disease 61 CP CPPS 61 Amiodarone 61 intracranial stenosis 61 artery stenosis 61 perindopril 61 beclomethasone dipropionate 61 Barrett esophagus BE 61 NSAID associated 61 parathyroid 61 hypoglycaemia 61 euvolemic hyponatremia 61 Pulmonary hypertension 61 serum triglycerides 61 PSADT 61 anticoagulation 61 chronic GVHD 61 selective COX 2 61 carotid IMT 61 syncope 61 hypokalemia 61 macrovascular complications 61 EDARBI 61 bivalirudin 61 serotonin syndrome 61 hypotension 61 corticosteroid dose 61 severe asthma exacerbations 61 prostate cancer CaP 61 heterozygous FH 61 tumor recurrence 61 Dronedarone 61 nonadherence 61 IPAH 61 CRBSI 61 Navelbine 61 hyperglycemia 61 NSTEMI 61 Heavy menstrual bleeding 61 thiazide diuretics 61 MAXALT 61 failure ADHF 61 INTEGRILIN 61 pathologic fracture 61 Atherosclerotic 61 bacterial prostatitis 61 LYSTEDA 61 COPD exacerbation 61 multivessel disease 61 del 5q MDS 61 coronary interventions 61 vasogenic edema 61 keloid formation 61 urinary calcium 61 Torisel 61 mcg QD 61 nesiritide 61 H2 antagonists 61 valvular heart disease 61 pulmonary embolisms 61 pCR 61 nephrotoxic 61 INVEGA ® 61 Endothelial dysfunction 61 ACE inhibitors 61 FROVA 61 embolic stroke 61 intravitreal injections 61 Infusion Reactions Severe 61 oral diclofenac 61 flecainide 61 hypercholesterolemia 61 Thal Dex 61 G CSFs 61 Estrogen deficiency 61 statins 61 coronary disease 61 PEGylated interferon beta 1a 61 vitreous hemorrhage 61 electrolyte abnormalities 61 levosimendan 61 hypertriglyceridemia 61 symptomatic hyponatremia 61 Hyperkalemia 61 gastrointestinal perforations 61 chronic immune thrombocytopenic 61 imipenem 61 Allergic Rhinitis 61 hyperammonemia 61 cardiac repolarization 61 Proteinuria 61 basal cell carcinoma BCC 61 NSAID therapy 61 NSAID 61 hypercalciuria 61 bypass graft CABG surgery 61 metastatic neuroendocrine tumors 61 serum urate 61 neovascular AMD 61 BENICAR HCT 61 drotrecogin alfa activated 61 induce regression 61 anti arrhythmic drugs 61 Losartan 61 pantoprazole 61 Ranolazine 61 atrial fibrillation 61 varicella infection 61 NYHA Class II 61 acute myocardial infarction 61 sudden cardiac death 61 Renal dysfunction 61 oral anticoagulation 61 LVSD 61 bone resorption 61 enzyme elevations 61 leukoencephalopathy 61 erythema nodosum 61 aortic stenosis 61 urolithiasis 61 incidence ≥ 61 celecoxib 61 ertapenem 61 PNH patients 61 neutrophil counts 61 Known hypersensitivity 61 Hashimoto thyroiditis 61 oxycodone CR 61 haemorrhagic strokes 61 abdominal adiposity 61 intraventricular hemorrhage 61 splenectomized patients 61 anticoagulation therapy 61 spironolactone 61 antidiabetic drugs 61 acid suppressive medication 61 Thromboembolic 61 insulin sensitizing 61 uncontrolled hypertension 61 cardiac valvulopathy 61 immunosuppressive agents 61 inflammatory biomarkers 61 severe hypoglycaemia 61 ramipril 61 metastatic malignant 61 ZOMETA 61 elevated intraocular pressure 61 liver transplant recipients 61 calcineurin inhibitors 61 vasovagal syncope 61 hematological parameters 61 postoperative bleeding 61 platelet inhibitor 61 colorectal carcinoma 61 streptokinase 61 intravesical therapy 61 TNF Tumor Necrosis Factor 61 serum phosphorous 61 left ventricular hypertrophy 61 CYPHER Stent 61 Ivabradine 61 MGUS 61 macroalbuminuria 61 angiotensin receptor blocker ARB 61 Myocardial infarction 61 antidiabetic drug 61 asymptomatic carotid stenosis 61 Anticoagulants 60 T1DM 60 Tumor shrinkage 60 DOXIL 60 RoACTEMRA 60 transaminase levels 60 riociguat 60 immunosuppressive therapies 60 Adverse events 60 Darapladib 60 interferon alfa 60 anticholinergic medications 60 impaired renal 60 neurologic symptoms 60 Neutropenia 60 symptomatic atrial fibrillation 60 premenstrual syndrome PMS 60 MICARDIS ® 60 TYSABRI treated 60 neurocognitive deficits 60 DFMO 60 anakinra 60 transdermal estrogen 60 ischemic vascular 60 aminotransferase ALT 60 Ischemic strokes 60 microalbuminuria 60 squamous cell cancers 60 monoamine oxidase inhibitors 60 parkinsonian symptoms 60 rosiglitazone 60 receptor blockers ARBs 60 allogeneic HSCT 60 NSAID induced GI 60 intracerebral 60 anticoagulant medication 60 serum potassium levels 60 deep venous thrombosis 60 cardioprotective effect 60 iron overload 60 macrolide antibiotic

Back to home page